The pharmaceutical industry veteran, who oversaw the 1996 merger of Sandoz AG and Ciba-Geigy AG that created Novartis, is set to be replaced by Bayer Healthcare Chairman Jörg Reinhardt.
Reinhardt lost out in the race to become Norvatis's chief executive in 2010, when Vasella separated the roles of chairman and CEO. His return has been hailed by Michael Leuchten, an analyst at Barclays Plc in London, who said that the 59 year-old "can hit the ground running".
The calendar you're trying to add has already been added to this event.
This is not a valid number
You are about to leave this page. Any changes you made will not be saved.
Are you sure?
What kind of event would you like to create?